View All
April 15, 2021 Off

Bristol Myers Squibb gets EC’s approval for Opdivo/Cabometyx combo for advanced renal cell carcinoma patients

By BusinessWire

Opdivo in combination with Cabometyx was generally well tolerated, with a low rate of treatment-related discontinuations.


View All
April 15, 2021 Off

Innovation Pharma’s Broad Spectrum Antiviral Drug Candidate Brilacidin Highlighted in Biodefense and Infectious Diseases COVID-19 Presentation

By GlobeNewswire

WAKEFIELD, Mass., April 14, 2021 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announced that Brilacidin, the Company’s defensin-mimetic drug candidate, was featured in...

My Pharmaceutical

View All
April 13, 2021 Off

Drug testing approach uncovers effective combination for treating small cell lung cancer

By Author

Researchers from the National Institutes of Health have identified and tested a drug combination that exploits a weakness in small cell lung cancer (SCLC), an aggressive, dangerous cancer. The scientists targeted a vulnerability in how the cancer cells reproduce, increasing...

March 25, 2021 Off

Scientists find evidence that novel coronavirus infects the mouth’s cells

By Author

An international team of scientists has found evidence that SARS-CoV-2, the virus that causes COVID-19, infects cells in the mouth....

December 3, 2020 Off

Understanding the role of inflammation in COVID-19 patients: a little is good, too much might kill you

By Dino Mustafić

COVID-19 is the medical emergency of the century. Since the pandemic began in December 2019, the new coronavirus, termed SARS-CoV-2...